CD44 and hepatocellular carcinoma: However, the Cd44 gene status had no influence on either the number of primary liver tumors detected or on the level of the hepatocellular carcinoma biomarker AFP (α-fetoprotein) in the serum of Nf2-mutant mice (Figure 6c,d).